GHDX

Genomic Health, Inc. News Headlines

$31.3099
*  
unch
unch
Get GHDX Alerts
*Delayed - data as of Dec. 22, 2014 9:40 ET  -  Find a broker to begin trading GHDX now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
View:    GHDX Pre-Market
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By
Genomic Health to Outperform - Analyst Blog
7/6/2012 2:30:01 PM - Zacks.com


Cepheid Expands European Portfolio - Analyst Blog
5/29/2012 2:30:01 PM - Zacks.com


FDA Nod for Cepheid's Infinity-80 - Analyst Blog
5/25/2012 9:44:31 AM - Zacks.com


Myriad in Research Partnership - Analyst Blog
5/22/2012 2:30:01 PM - Zacks.com


Genomic Health Stays Neutral - Analyst Blog
5/21/2012 2:39:05 PM - Zacks.com


Myriad Reiterated Neutral - Analyst Blog
5/18/2012 1:40:41 PM - Zacks.com


Cepheid Back to Neutral - Analyst Blog
5/14/2012 2:06:48 PM - Zacks.com


Will Mayo v. Prometheus Fire Up Pharma?: Kevin DeGeeter
5/10/2012 4:42:02 PM - International Business Times


Genomic Health Beats Estimates - Analyst Blog
5/3/2012 11:49:17 AM - Zacks.com


Myriad Beats, Raises Guidance - Analyst Blog
5/2/2012 2:45:01 PM - Zacks.com


Insiders are Spending MILLIONS on These 4 Small-Cap Stocks
4/10/2012 10:30:00 AM - Andy Obermueller


Cepheid Upgraded to Outperform - Analyst Blog
4/9/2012 2:30:01 PM - Zacks.com


Positive Data from Genomic Health - Analyst Blog
3/22/2012 2:21:50 PM - Zacks.com


Statins, Genomics, Patents, And Speculation
3/6/2012 1:11:00 PM - Seeking Alpha


Market's Reaction To M&A Possibilities In Sequencing Companies
3/6/2012 11:06:00 AM - Seeking Alpha


Myriad: Prolaris a Useful Test - Analyst Blog
2/28/2012 5:00:01 PM - Zacks.com


4 Stocks With Heavy Insider Buying
2/24/2012 8:34:00 AM - Seeking Alpha


Reiterating Genomic at Neutral - Analyst Blog
2/15/2012 2:45:01 PM - Zacks.com


Reiterating Cepheid at Neutral - Analyst Blog
2/14/2012 2:30:01 PM - Zacks.com


Genomic Misses, Grows Annually - Analyst Blog
2/7/2012 10:30:01 AM - Zacks.com


Myriad Beats, Raises Guidance - Analyst Blog
2/1/2012 8:00:01 AM - Zacks.com


Genomic's Useful Colon Cancer Test - Analyst Blog
1/23/2012 2:45:01 PM - Zacks.com


Myriad Gets Rights to RAD51C Gene - Analyst Blog
1/19/2012 2:45:01 PM - Zacks.com


Insiders Love These 18 High Growth Stocks
1/18/2012 3:21:00 PM - Seeking Alpha


Genomic Looks to Diversify Offering (revised) - Analyst Blog
1/11/2012 11:48:01 AM - Zacks.com